ParsiKZhangLWhiteleyMS, et al.899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: the untold story of cyanoacrylate adhesive closure. Phlebol J Venous Dis2023; 39: 02683555231211086.
2.
YiğitG. Outcomes of cyanoacrylate closure of the truncal varicose vein insufficiency: a comparison between young and elderly patients. Phlebology2023; 38: 119–128.
3.
KelesE. Complications of cyanoacrylate adhesive closure therapy in chronic venous insufficiency: a single center, single-surgeon study. Phlebology2023; 38: 2683555231190266.
4.
O’BanionLAASiadaSCutlerB, et al.Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: outcomes of a multicenter real-world experience. J Vasc Surg Venous Lymphat Disord2022; 10: 1221–1228.
5.
TangTYRathnaweeraHPKamJW, et al.Endovenous cyanoacrylate glue to treat varicose veins and chronic venous insufficiency-experience gained from our first 100+ truncal venous ablations in a multi-ethnic Asian population using the Medtronic VenaSealTM Closure System. Phlebology2019; 34: 543–551.
6.
ChanSSJYapCJQTanSG, et al.The utility of endovenous cyanoacrylate glue ablation for incompetent saphenous veins in the setting of venous leg ulcers. J Vasc Surg Venous Lymphat Disord2020; 8: 1041–1048.
7.
KoreptaLWardMBlechaM, et al.A contemporary comparison of cyanoacrylate, radiofrequency, and endovenous laser ablation on healing of active venous ulceration. Ann Vasc Surg2022; 87: 237–244.
8.
BĕlohlávekJDytrychVLinhartA. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol2013; 18: 129–138.
AlmeidaJIJavierJJMackayE, et al.First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord2013; 1: 174–180.
11.
GibsonKFerrisB. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular2017; 25: 149–156.
12.
MorrisonNGibsonKVasquezM, et al.Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord2020; 8: 978–989.
13.
ProebstleTAlmJDimitriS, et al.Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord2021; 9: 329–334.
14.
MorrisonNGibsonKMcEnroeS, et al.Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg2015; 61: 985–994.
15.
ProebstleTMAlmJDimitriS, et al.The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord2015; 3: 2–7.
16.
AlmeidaJIJavierJJMackayEG, et al.Three-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord2015; 3: 125.
17.
GibsonKMorrisonNKolluriR, et al.Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 2018; 6: 606–613.
18.
ZernovickyF. Fast progressive devastating granulomatic reaction after VenaSeal procedure. Int Angiol2018; 37: 168–169.
